Cases of drug-resistant epilepsy are predicted to increase by more than 100,000 by the year 2026, according to data and analytics company, GlobalData.
Epilepsy
The forecasted rise from 1,601,859 prevalent cases of active epilepsy (2016 figure) to 1,711,113 (2026 predicted figure) covers the seven major markets — US, France, Germany, UK, Italy, Spain and Japan.